Becton, Dickinson and Company
One Becton Drive
598 articles with Becton, Dickinson and Company
Vulnerabilities found in BD Alaris Gateway Workstation affirmed by ICS-CERT with CVSS scores of 10.0 and 7.3 respectively
Becton, Dickinson and Company announced the early tender results for its previously announced tender offers to purchase for cash, in the order of priority set forth in the table below, up to the applicable Tender SubCap, if any, of each of the Company's 5.000% Notes due 2040, 4.875% Notes due 2044, 4.685% Notes due 2044, 3.700% Notes due 2027, 3.734% Notes due 2024, 4.669% Notes due 2047 and 2.894% Notes due 2022
Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities - May 20, 2019
Becton, Dickinson and Company announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the table below.
The company reaffirmed its full fiscal year 2019 comparable, currency-neutral revenue guidance, and updated its adjusted diluted earnings per share guidance.
BD announced that it will present at the Bank of America Merrill Lynch 2019 Global Healthcare Conference on Tuesday, May 14, 2019, at 10:00 a.m. ET.
New BD ChloraPrep™ Skin Preparation is the Only Commercially Available CHG Antiseptic Skin Preparation with Sterile Solution Designation in the U.S.
The Board of Directors of BD has declared a quarterly dividend of $0.77 per common share, payable on June 28, 2019 to holders of record on June 7, 2019.
BD Unveils Platelet Quality Control Media to Help Reduce the Incidence of Sepsis in Patients Requiring Platelet Transfusion
BD BACTEC™ Platelet Quality Control Media is cleared by the U.S. Food and Drug Administration and CE-IVD marked for platelet testing
BD announced that it will conduct a live webcast of its second fiscal quarter 2019 earnings conference call on Thursday, May 9, 2019, at 8:00 a.m..
BD FACSDuet™ system raises the bar on flow cytometry automation offering a fully integrated sample-to-answer solution with the BD FACSLyric™ clinical flow cytometer
BD, a leading global medical technology company, issued the following statement related to the recent letter from FDA to health care providers regarding paclitaxel-coated devices:
Venovo™ Venous Stent proven safe and effective in iliac and femoral veins
VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD
VIVA Physicians announced the selection of NAMSA as the independent statistical analysis group to examine individual patient-level data associated with paclitaxel-coated balloons and stent trials used in the treatment of peripheral artery disease in the superficial femoral artery.
BD, a leading global medical technology company, announced that it will present at the Barclays Global Healthcare Conference on Tuesday, March 12, 2019, at 2:05 p.m. ET.
As reported, revenues of $4.160 billion increased 35.1 percent.
BD Nano™ Second Generation Pen Needle Receives 510(k) Clearance from U.S. Food and Drug Administration
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on March 29, 2019 to holders of record on March 8, 2019.
- Preliminary reported revenues of $4.160 billion increased 35.1 percent. - On a comparable, currency-neutral basis, preliminary revenues increased 5.2 percent. - As reported, preliminary diluted earnings per share of $2.05 increased 369.7 percent. - As adjusted, preliminary diluted earnings per share of $2.70 increased 8.9 percent, or 14.9 percent on a currency-neutral basis. - The company reaffirms previously issued fiscal year 2019 revenue and adjusted
BD (Becton, Dickinson and Company) announced today that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 22, 2019, at 1 p.m. (ET).
BD (Becton, Dickinson and Company) announced today that it will conduct a live webcast of its first fiscal quarter 2019 earnings conference call on Tuesday, February 5, 2019, at 8:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.